Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FM50N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,675
Award facts
- Contract value 100% obligated
- $19,675.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,675.20 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) on January 30, 2026, with completion scheduled for February 2, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor within the federal medical procurement ecosystem, primarily serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of federal contracts demonstrates consistent capability in fulfilling competitive procurement requirements across a broad spectrum of pharmaceutical products, ranging from specialty medications to generic drugs, vaccines, and medical devices. This particular delivery order for RINVOQ ER—a treatment medication—exemplifies the company's role in supplying essential pharmaceutical commodities to support military healthcare operations and troop readiness initiatives.
Quick answers
Who was awarded contract SPE2DR26FM50N?
SPE2DR26FM50N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26FM50N worth?
The government has obligated $19,675 on SPE2DR26FM50N.
Is contract SPE2DR26FM50N an order under another contract?
Yes. SPE2DR26FM50N is a delivery order under SPE2DR25D2007, an indefinite delivery contract.
Was contract SPE2DR26FM50N competed?
The extent of competition for SPE2DR26FM50N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award